DAWN
Day One Biopharmaceuticals Inc

1,866
Mkt Cap
$873.77M
Volume
4.00
52W High
$13.53
52W Low
$5.64
PE Ratio
-5.67
DAWN Fundamentals
Price
$8.42
Prev Close
$8.51
Open
$8.50
50D MA
$8.18
Beta
1.12
Avg. Volume
3.31M
EPS (Annual)
-$1.02
P/B
1.92
Rev/Employee
$724,646.41
Loading...
Loading...
News
all
press releases
Day One Biopharmaceuticals (NASDAQ:DAWN) Stock Price Down 4.9% - What's Next?
Day One Biopharmaceuticals (NASDAQ:DAWN) Trading Down 4.9% - Should You Sell...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Day One Biopharmaceuticals (NASDAQ:DAWN) Sees Large Volume Increase - Time to Buy?
Day One Biopharmaceuticals (NASDAQ:DAWN) Sees Large Volume Increase - Time to Buy...
MarketBeat·4d ago
News Placeholder
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives Average Recommendation of "Moderate Buy" from Analysts
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Get Free Report) has earned a consensus rating of "Moderate Buy" from the nine brokerages that are presently covering the company, Marketbeat Ratings...
MarketBeat·4d ago
News Placeholder
180,133 Shares in Day One Biopharmaceuticals, Inc. $DAWN Bought by Schroder Investment Management Group
Schroder Investment Management Group acquired a new stake in shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Free Report) during the second quarter, according to its most recent Form 13F...
MarketBeat·5d ago
News Placeholder
Day One Biopharmaceuticals, Inc. $DAWN Shares Purchased by Geode Capital Management LLC
Geode Capital Management LLC boosted its position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Free Report) by 11.2% during the second quarter, according to the company in its most recent...
MarketBeat·8d ago
News Placeholder
Day One Biopharmaceuticals, Inc. $DAWN Shares Purchased by Virtus Investment Advisers LLC
Virtus Investment Advisers LLC increased its position in shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Free Report) by 137.0% during the second quarter, according to its most recent Form...
MarketBeat·12d ago
News Placeholder
Day One Biopharmaceuticals (NASDAQ:DAWN) Trading 8% Higher - Still a Buy?
Day One Biopharmaceuticals (NASDAQ:DAWN) Trading Up 8% - Here's Why...
MarketBeat·16d ago
News Placeholder
Day One Biopharmaceuticals' (DAWN) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright reaffirmed a "buy" rating and issued a $25.00 price target on shares of Day One Biopharmaceuticals in a research note on Monday...
MarketBeat·17d ago
News Placeholder
Day One Biopharmaceuticals, Inc. $DAWN Shares Purchased by Dynamic Technology Lab Private Ltd
Dynamic Technology Lab Private Ltd increased its stake in shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Free Report) by 71.7% during the second quarter, according to the company in its...
MarketBeat·18d ago
News Placeholder
Jeremy Bender Sells 15,894 Shares of Day One Biopharmaceuticals (NASDAQ:DAWN) Stock
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Get Free Report) CEO Jeremy Bender sold 15,894 shares of the business's stock in a transaction that occurred on Monday, November 17th. The shares were...
MarketBeat·22d ago

Latest DAWN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.